Bifogade filer
Observe_Medical_ASA_Company_Presentation
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2025-06-12 11:40:08
Oslo, June 12, 2025 - Observe Medical ASA («Observe Medical» or the «Company»)
refers to the stock exchange announcements dated 11 June 2024 regarding
the private placement.
Observe Medical is happy to announce the positive market reception of UnoMeter
Safeti Plus. Since the first delivery in January 2025, the product has gained
significant traction, reflecting strong demand and customer confidence. Key
highlights include:
· Market Re-establishment: Sales have been re-established in countries
representing 85% of Convatec's 2021 market for the product.
· Global Reach: Orders received from 27 countries, with 16 countries placing
multiple/repeat orders. For the whole UnoMeter portfolio, the Company has
received orders from 33 countries.
· Order Intake: Based on a 6-month rolling order intake, the company has
achieved an annualized order intake of approximately NOK 30 million.
· Operational Focus: The company is focused on further penetrating this
market, building on the success of UnoMeter Safeti Plus.
· Financing: With a successful private placement, strong support from our
shareholders, and substantial backing from our creditors through a significant
debt reduction, the company is positioned to advance its operational and
strategic agenda, including the realization of UnoMeter Safeti Max and Sippi.
Please find the updated company presentation attathed. The presentation can also
be found at www.observemedical.com.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.